PZPeihai Zhang

Peihai Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Peihai Zhang has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Ziyang Ma

    Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China

    5 shared publications
  • Jintao Wei

    Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China

    3 shared publications
  • Yang Liu

    Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China

    3 shared publications
  • Shikuan Lu

    Hospital of Chengdu University of Traditional Chinese Medicine

    2 shared publications
  • Yipeng Zhao

    Hospital of Chengdu University of Traditional Chinese Medicine

    2 shared publications
  • Bailong Jiang

    Department of Urology, Hospital of Chengdu University of Traditional Chinese Medicine

    1 shared publication

Latest Publications

  • Open Access

    Erdi Bazhen decoction for cancer-related fatigue due to qi and blood deficiency in prostate cancer patients receiving androgen deprivation therapy: an exploratory randomized, double-blind, placebo-controlled pilot clinical trial protocol

    by Jintao Wei, Jian Ma, Ziyang Ma, Yang Liu, Lei Xu, Xuefeng Mei, Peihai Zhang

    Background: Prostate cancer is the most common male genitourinary malignancy in China. Long-term androgen deprivation therapy (ADT) causes severe cancer-related fatigue (CRF), which impairs patients’ physical function and quality of life. Currently, there is a lack of safe, long-term specific pharmacological agents for this condition in Western medicine. From the perspective of traditional Chinese medicine (TCM), qi and blood deficiency is the core pathogenesis underlying the occurrence and progression of CRF. Erdi Bazhen Decoction (EBD) has shown favorable clinical effects on fatigue after ADT in routine practice, but high-quality clinical evidence remains scarce, and key parameters for large-scale confirmatory trials remain undetermined. This exploratory pilot trial aims to investigate the preliminary efficacy and safety of EBD granules for CRF in prostate cancer patients receiving ADT, and to estimate critical trial parameters including effect size, recruitment rate, adherence and dropout rate to inform the design of a future large-scale confirmatory RCT. Methods: This single-center, prospective, randomized, double-blind, placebo-controlled parallel pilot trial will enroll 50 eligible patients from a single hospital. Participants will be randomly assigned to two groups at a 1:1 ratio. Both groups will receive routine supportive care for 4 weeks. The intervention group will receive EBD granules, and the control group will receive matched placebo granules. The primary exploratory efficacy endpoint is the change in total score of the revised Piper Fatigue Scale (PFS-R) from baseline to week 4. Secondary outcomes include quality of life, physical performance and TCM syndrome scores; hemoglobin and C-reactive protein levels will be assessed as exploratory biomarkers. Trial feasibility parameters such as recruitment rate, medication adherence and dropout rate will also be descriptively analyzed to inform future trial design. Safety indicators and adverse events will be fully recorded. Variable block randomization without stratification and full double-blinding will be implemented. The primary analysis will be conducted in the intention-to-treat population; a per-protocol analysis will be performed as a sensitivity analysis. All efficacy estimates are exploratory. This protocol was designed in accordance with the SPIRIT 2025 statement; trial results will be reported in accordance with the CONSORT 2025 statement. Conclusion: This standardized pilot controlled trial will provide preliminary clinical evidence and essential methodological parameters for EBD in relieving ADT-related fatigue. The results may offer preliminary support for a safe TCM regimen to improve patients’ fatigue, physical status and quality of life, and lay a methodological foundation for integrated Chinese and Western medicine management of prostate cancer-related fatigue. As an exploratory pilot study, the single-center design, small sample size and short intervention period limit the generalizability of confirmatory conclusions. Further large-scale, multi-center, long-term confirmatory trials are needed to verify the long-term effects and population applicability of EBD. Clinical Trial Registration: https://itmctr.ccebtcm.org.cn/ , identifier [ITMCTR2026001527].

  • Open Access

    Interpretable machine learning uncovers core seminal microbial signatures in idiopathic oligoasthenospermia

    by Shikuan Lu, Yipeng Zhao, Yuxin Zhao, Huangtang Dong, Chunxu Qu, Weicai Zhong, Peihai Zhang, Ziyang Ma, Pengfei Zhang

    Background: Previous studies have confirmed that changes in semen microbiota are closely related to male oligoasthenospermia(OA). However, current research only qualitatively describes the differences in the microbial community, fails to screen out core markers with independent discriminatory value, and also fails to quantitatively evaluate the diagnostic efficacy of the microbial community, resulting in insufficient research on the diagnostic value of the semen microbiota in oligoasthenospermia. Methods: A total of 40 untreated patients with idiopathic oligoasthenospermia (IOA) and 30 fertile control (FC) were recruited for this study. The semen samples were sequenced using 16S rRNA sequencing technology to assess the differences in microbial diversity and abundance. Subsequently, three machine learning algorithms were employed to further identify the core microorganisms and to further evaluate the diagnostic performance. Then, the SHapley Additive exPlanations(SHAP)analysis method was used to explain the contribution of these core microbiota to the disease. Additionally, the Phylogenetic Investigation of Communities by Reconstruction of Unobserved States 2 (PICRUSt2) algorithm was used to predict the functions of the core microorganisms. Results: The analysis of the microbial community in semen revealed that there were differences in the internal composition structure of the semen microbiota between the IOA group and the FC group. Machine learning algorithms identified a total of 5 core bacterial genera. The area under the curve (AUC) of this model was 0.773, with a 95% confidence interval (CI) of 0.661–0.885, indicating that the model has strong discriminatory power. SHAP analysis further revealed the direction of the association between the abundance of the microbiota and disease prediction. Additionally, KEGG pathway prediction revealed that the 5 core genera were predominantly enriched in carbohydrate and nucleic acid metabolism pathways, most notably glycolysis/gluconeogenesis ( P = 6.67 × 10 -3 ). Conclusion: This study employed a variety of machine learning algorithms to conduct a systematic characterization study on the semen microbiota of patients with idiopathic oligoasthenospermia. This method overcomes the limitations of traditional microbiota analysis and can This approach overcame the limitations of traditional microbiota analysis and constructed a risk prediction model based on core bacterial genera. It preliminarily explored the potential of the semen microbiota as a non-invasive screening candidate marker for IOA, providing a reference for subsequent research on non-invasive diagnostic markers and mechanisms., providing a basis for non-invasive precise diagnosis of the disease and the analysis of the pathogenic mechanism of the microbiome.

  • Open Access

    Resveratrol in benign prostatic hyperplasia: mechanistic insights and therapeutic perspectives

    by Bailong Jiang, Tao Zhang, Maobin Yu, Yaodong You, Huawei Liu, Jinze Li, Peihai Zhang

    Benign prostatic hyperplasia (BPH) is a common age-related disorder characterized by progressive prostatic enlargement and lower urinary tract symptoms, yet current medical therapies remain constrained by delayed onset, incomplete efficacy, and treatment-related adverse effects. Resveratrol (Res), a naturally occurring polyphenol, has emerged as a promising candidate for BPH intervention because its pharmacological profile aligns closely with the multifactorial biology of the disease. This review synthesizes current evidence showing that Res may counteract BPH progression through coordinated regulation of several interconnected processes, including abnormal prostate cell proliferation, apoptosis resistance, oxidative stress, chronic inflammation, fibrotic remodeling, and androgen-related signaling. Rather than acting on a single target, Res appears to reshape the pro-hyperplastic microenvironment at multiple levels, providing a mechanistic rationale for its therapeutic potential. However, the available evidence remains predominantly preclinical, and its clinical translation is still limited by poor oral bioavailability, extensive first-pass metabolism, uncertainty regarding the active molecular species in prostate tissue, and the lack of standardized formulations and robust clinical trials. Overall, Res represents a biologically plausible but not yet clinically established strategy for BPH management.

  • Open Access

    Spatial analysis of predictors of prostate cancer incidence in the united states using multiscale geographically weighted regression (MGWR)

    by Yang Liu, Peihai Zhang, Ziyang Ma, Jintao Wei

    Prostate cancer incidence varies markedly across the United States (U.S.), yet the broad contextual predictors associated with this variation and the spatial scales at which these associations operate remain insufficiently characterized within a unified spatial framework. This study aimed to examine annual state-level associations between prostate cancer incidence and selected contextual predictors across the U.S. from 2018 to 2022 using Multiscale Geographically Weighted Regression (MGWR). Five annual state-level datasets covering the 50 U.S. states were assembled for 2018-2022. After exploratory spatial analysis, correlation screening, collinearity diagnostics, theory-informed re-evaluation, and representative-year sensitivity analyses, six predictors were retained for the final annual models: elevation, rainfall, atmospheric pressure, obesity prevalence, the percentage of males aged 65 years and older among the male population, and the percentage of the Black or African American alone population. Ordinary Least Squares (OLS), Geographically Weighted Regression (GWR), and MGWR were fitted separately for each annual dataset. Model performance was compared using R², adjusted R², residual sum of squares, corrected Akaike information criterion (AICc), bandwidth diagnostics, and residual spatial autocorrelation. Across all five annual analyses, MGWR showed the most favorable overall performance, with adjusted R² values ranging from 0.555 to 0.618 and AICc values ranging from 124.934 to 132.779. MGWR also identified variable-specific adaptive bandwidths ranging from 24 to 40 nearest neighbors, indicating spatial scale heterogeneity among predictors. Local coefficient surfaces showed clear spatial non-stationarity in both coefficient magnitude and, for some predictors, coefficient direction. Residual Moran's I tests were non-significant for all five annual models, suggesting that substantial residual spatial autocorrelation had been reduced after model fitting. Multivariate clustering of standardized local coefficients further revealed recurring regional groupings in coefficient-pattern similarity. At the state level in the U.S., prostate cancer incidence was associated with geographically differentiated contextual patterns rather than a single spatially uniform relationship structure. In this setting, the main value of MGWR lay in its ability to characterize multi-scale and regionally varying association patterns across repeated annual spatial analyses. These findings may support geographically differentiated surveillance and future hypothesis generation while underscoring the importance of considering spatial heterogeneity in ecological studies of prostate cancer incidence.


  • Open Access

    Comprehensive microbiome and metabolome analysis revealed the changes of semen microbial characteristics and metabolic phenotypes in patients with idiopathic oligoasthenozoospermia

    by Shikuan Lu, Zhiyu Wu, Yipeng Zhao, Tang Tang, Ye Dong, Meilin Wu, Peihai Zhang, Ziyang Ma

    Background: The etiology and pathogenesis of idiopathic oligoasthenospermia (IOA) remain unclear, and current treatment options yield suboptimal outcomes. Consequently, there is an urgent need to identify novel biomarkers and develop diagnostic tools to improve patient identification and clinical management. Multi-omics technologies offer a promising pathway toward achieving this goal in the future. Methods: This study included 40 untreated patients with idiopathic oligoasthenospermia (IOA) and 30 healthy fertile males (HP) as controls. Semen samples were analyzed using 16S rRNA gene sequencing (microbiome) and non-targeted metabolomics (GC-MS/LC-MS coupled). A microbe-metabolite association network was integrated at the genus level based on Spearman correlation algorithms. Results: Semen microbiome analysis revealed that both microbial composition and species richness differed between IOA patients and HP controls. Non-targeted metabolomics further demonstrated characteristic metabolic dysregulation in seminal plasma of IOA patients, with a metabolic signature effectively distinguishing cases from controls (VIP > 1, FDR < 0.05). KEGG pathway enrichment analysis indicated that differentially expressed metabolites primarily involved amino acid metabolism, carbohydrate metabolism, and related signaling pathways (corrected p-value < 0.05). Construction of a Spearman correlation network between microbiota and metabolites (|r| > 0.6) identified significant interactions between core bacterial genera such as Dialister , Prevotellaceae_NK3B31_group , Lawsonella , and Blautia with seminal plasma metabolites, suggesting potential involvement of the microbiota-metabolite axis in the pathological process of IOA. Conclusion: The microbial community structure and metabolic profiles in the semen of IOA patients exhibit significant disruption. Diagnostic models constructed based on combined microbial-metabolite features demonstrate potential for effectively distinguishing disease phenotypes. The core dysregulated bacterial genera, associated metabolites, and related pathways may serve as early diagnostic biomarkers and therapeutic intervention targets.


  • Er-Chen decoction alleviates spermatogenic dysfunction in obese mice by tuning the SIRT1/p53 axis

    by Maohui Liu, Jiawei Chen, Zubing Zhou, Jiexin Wang, Guangsen Li, Jinghui Xie, Lingmiao Wen, Huan Wang, Rong Gan, Peihai Zhang, et al.